1. Home
  2. GRFS vs SNEX Comparison

GRFS vs SNEX Comparison

Compare GRFS & SNEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$9.02

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo StoneX Group Inc.

SNEX

StoneX Group Inc.

HOLD

Current Price

$98.58

Market Cap

4.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRFS
SNEX
Founded
1940
1924
Country
Spain
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
4.9B
IPO Year
2006
1994

Fundamental Metrics

Financial Performance
Metric
GRFS
SNEX
Price
$9.02
$98.58
Analyst Decision
Hold
Buy
Analyst Count
2
1
Target Price
$10.15
N/A
AVG Volume (30 Days)
551.2K
393.3K
Earning Date
01-01-0001
02-04-2026
Dividend Yield
1.58%
N/A
EPS Growth
N/A
10.92
EPS
0.64
5.89
Revenue
$8,821,017,248.00
$130,897,700,000.00
Revenue This Year
$5.36
N/A
Revenue Next Year
$5.15
$5.74
P/E Ratio
$17.99
$16.65
Revenue Growth
7.31
32.62
52 Week Low
$6.19
$63.64
52 Week High
$11.14
$106.98

Technical Indicators

Market Signals
Indicator
GRFS
SNEX
Relative Strength Index (RSI) 53.16 59.43
Support Level $8.69 $95.36
Resistance Level $9.22 $99.10
Average True Range (ATR) 0.18 2.98
MACD 0.03 0.30
Stochastic Oscillator 64.15 71.43

Price Performance

Historical Comparison
GRFS
SNEX

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About SNEX StoneX Group Inc.

StoneX Group Inc is a Global brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, Global payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.

Share on Social Networks: